Report Detail

Other Global DNA Medicine Based on DNA Modification Market Growth (Status and Outlook) 2022-2028

  • RnM4495233
  • |
  • 10 November, 2022
  • |
  • Global
  • |
  • 103 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

The global market for DNA Medicine Based on DNA Modification is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key DNA Medicine Based on DNA Modification players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global DNA Medicine Based on DNA Modification market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global DNA Medicine Based on DNA Modification market, with both quantitative and qualitative data, to help readers understand how the DNA Medicine Based on DNA Modification market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the DNA Medicine Based on DNA Modification market and forecasts the market size by Type (Viral and Non-viral,), by Application (Neurological Diseases, Cancer and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Viral
Non-viral

Segmentation by application
Neurological Diseases
Cancer
Other

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

Chapter Introduction
Chapter 1: Scope of DNA Medicine Based on DNA Modification, Research Methodology, etc.
Chapter 2: Executive Summary, global DNA Medicine Based on DNA Modification market size and CAGR, DNA Medicine Based on DNA Modification market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: DNA Medicine Based on DNA Modification revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global DNA Medicine Based on DNA Modification revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global DNA Medicine Based on DNA Modification market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global DNA Medicine Based on DNA Modification Market Size 2017-2028
    • 2.1.2 DNA Medicine Based on DNA Modification Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 DNA Medicine Based on DNA Modification Segment by Type
    • 2.2.1 Viral
    • 2.2.2 Non-viral
  • 2.3 DNA Medicine Based on DNA Modification Market Size by Type
    • 2.3.1 DNA Medicine Based on DNA Modification Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
  • 2.4 DNA Medicine Based on DNA Modification Segment by Application
    • 2.4.1 Neurological Diseases
    • 2.4.2 Cancer
    • 2.4.3 Other
  • 2.5 DNA Medicine Based on DNA Modification Market Size by Application
    • 2.5.1 DNA Medicine Based on DNA Modification Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)

3 DNA Medicine Based on DNA Modification Market Size by Player

  • 3.1 DNA Medicine Based on DNA Modification Market Size Market Share by Players
    • 3.1.1 Global DNA Medicine Based on DNA Modification Revenue by Players (2020-2022)
    • 3.1.2 Global DNA Medicine Based on DNA Modification Revenue Market Share by Players (2020-2022)
  • 3.2 Global DNA Medicine Based on DNA Modification Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 DNA Medicine Based on DNA Modification by Regions

  • 4.1 DNA Medicine Based on DNA Modification Market Size by Regions (2017-2022)
  • 4.2 Americas DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
  • 4.3 APAC DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
  • 4.4 Europe DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas DNA Medicine Based on DNA Modification Market Size by Country (2017-2022)
  • 5.2 Americas DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
  • 5.3 Americas DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC DNA Medicine Based on DNA Modification Market Size by Region (2017-2022)
  • 6.2 APAC DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
  • 6.3 APAC DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe DNA Medicine Based on DNA Modification by Country (2017-2022)
  • 7.2 Europe DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
  • 7.3 Europe DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa DNA Medicine Based on DNA Modification by Region (2017-2022)
  • 8.2 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global DNA Medicine Based on DNA Modification Market Forecast

  • 10.1 Global DNA Medicine Based on DNA Modification Forecast by Regions (2023-2028)
    • 10.1.1 Global DNA Medicine Based on DNA Modification Forecast by Regions (2023-2028)
    • 10.1.2 Americas DNA Medicine Based on DNA Modification Forecast
    • 10.1.3 APAC DNA Medicine Based on DNA Modification Forecast
    • 10.1.4 Europe DNA Medicine Based on DNA Modification Forecast
    • 10.1.5 Middle East & Africa DNA Medicine Based on DNA Modification Forecast
  • 10.2 Americas DNA Medicine Based on DNA Modification Forecast by Country (2023-2028)
    • 10.2.1 United States DNA Medicine Based on DNA Modification Market Forecast
    • 10.2.2 Canada DNA Medicine Based on DNA Modification Market Forecast
    • 10.2.3 Mexico DNA Medicine Based on DNA Modification Market Forecast
    • 10.2.4 Brazil DNA Medicine Based on DNA Modification Market Forecast
  • 10.3 APAC DNA Medicine Based on DNA Modification Forecast by Region (2023-2028)
    • 10.3.1 China DNA Medicine Based on DNA Modification Market Forecast
    • 10.3.2 Japan DNA Medicine Based on DNA Modification Market Forecast
    • 10.3.3 Korea DNA Medicine Based on DNA Modification Market Forecast
    • 10.3.4 Southeast Asia DNA Medicine Based on DNA Modification Market Forecast
    • 10.3.5 India DNA Medicine Based on DNA Modification Market Forecast
    • 10.3.6 Australia DNA Medicine Based on DNA Modification Market Forecast
  • 10.4 Europe DNA Medicine Based on DNA Modification Forecast by Country (2023-2028)
    • 10.4.1 Germany DNA Medicine Based on DNA Modification Market Forecast
    • 10.4.2 France DNA Medicine Based on DNA Modification Market Forecast
    • 10.4.3 UK DNA Medicine Based on DNA Modification Market Forecast
    • 10.4.4 Italy DNA Medicine Based on DNA Modification Market Forecast
    • 10.4.5 Russia DNA Medicine Based on DNA Modification Market Forecast
  • 10.5 Middle East & Africa DNA Medicine Based on DNA Modification Forecast by Region (2023-2028)
    • 10.5.1 Egypt DNA Medicine Based on DNA Modification Market Forecast
    • 10.5.2 South Africa DNA Medicine Based on DNA Modification Market Forecast
    • 10.5.3 Israel DNA Medicine Based on DNA Modification Market Forecast
    • 10.5.4 Turkey DNA Medicine Based on DNA Modification Market Forecast
    • 10.5.5 GCC Countries DNA Medicine Based on DNA Modification Market Forecast
  • 10.6 Global DNA Medicine Based on DNA Modification Forecast by Type (2023-2028)
  • 10.7 Global DNA Medicine Based on DNA Modification Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Biogen
    • 11.1.1 Biogen Company Information
    • 11.1.2 Biogen DNA Medicine Based on DNA Modification Product Offered
    • 11.1.3 Biogen DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Biogen Main Business Overview
    • 11.1.5 Biogen Latest Developments
  • 11.2 Novartis
    • 11.2.1 Novartis Company Information
    • 11.2.2 Novartis DNA Medicine Based on DNA Modification Product Offered
    • 11.2.3 Novartis DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Novartis Main Business Overview
    • 11.2.5 Novartis Latest Developments
  • 11.3 Gilead Sciences
    • 11.3.1 Gilead Sciences Company Information
    • 11.3.2 Gilead Sciences DNA Medicine Based on DNA Modification Product Offered
    • 11.3.3 Gilead Sciences DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Gilead Sciences Main Business Overview
    • 11.3.5 Gilead Sciences Latest Developments
  • 11.4 Sarepta Therapeutics
    • 11.4.1 Sarepta Therapeutics Company Information
    • 11.4.2 Sarepta Therapeutics DNA Medicine Based on DNA Modification Product Offered
    • 11.4.3 Sarepta Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Sarepta Therapeutics Main Business Overview
    • 11.4.5 Sarepta Therapeutics Latest Developments
  • 11.5 Alnylam Pharmaceuticals
    • 11.5.1 Alnylam Pharmaceuticals Company Information
    • 11.5.2 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Product Offered
    • 11.5.3 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Alnylam Pharmaceuticals Main Business Overview
    • 11.5.5 Alnylam Pharmaceuticals Latest Developments
  • 11.6 Amgen
    • 11.6.1 Amgen Company Information
    • 11.6.2 Amgen DNA Medicine Based on DNA Modification Product Offered
    • 11.6.3 Amgen DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Amgen Main Business Overview
    • 11.6.5 Amgen Latest Developments
  • 11.7 Spark Therapeutics
    • 11.7.1 Spark Therapeutics Company Information
    • 11.7.2 Spark Therapeutics DNA Medicine Based on DNA Modification Product Offered
    • 11.7.3 Spark Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Spark Therapeutics Main Business Overview
    • 11.7.5 Spark Therapeutics Latest Developments
  • 11.8 Akcea Therapeutics
    • 11.8.1 Akcea Therapeutics Company Information
    • 11.8.2 Akcea Therapeutics DNA Medicine Based on DNA Modification Product Offered
    • 11.8.3 Akcea Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Akcea Therapeutics Main Business Overview
    • 11.8.5 Akcea Therapeutics Latest Developments
  • 11.9 bluebird bio
    • 11.9.1 bluebird bio Company Information
    • 11.9.2 bluebird bio DNA Medicine Based on DNA Modification Product Offered
    • 11.9.3 bluebird bio DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 bluebird bio Main Business Overview
    • 11.9.5 bluebird bio Latest Developments
  • 11.10 Sunway Biotech
    • 11.10.1 Sunway Biotech Company Information
    • 11.10.2 Sunway Biotech DNA Medicine Based on DNA Modification Product Offered
    • 11.10.3 Sunway Biotech DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Sunway Biotech Main Business Overview
    • 11.10.5 Sunway Biotech Latest Developments
  • 11.11 SIBIONO
    • 11.11.1 SIBIONO Company Information
    • 11.11.2 SIBIONO DNA Medicine Based on DNA Modification Product Offered
    • 11.11.3 SIBIONO DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 SIBIONO Main Business Overview
    • 11.11.5 SIBIONO Latest Developments
  • 11.12 AnGes
    • 11.12.1 AnGes Company Information
    • 11.12.2 AnGes DNA Medicine Based on DNA Modification Product Offered
    • 11.12.3 AnGes DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 AnGes Main Business Overview
    • 11.12.5 AnGes Latest Developments
  • 11.13 Orchard Therapeutics
    • 11.13.1 Orchard Therapeutics Company Information
    • 11.13.2 Orchard Therapeutics DNA Medicine Based on DNA Modification Product Offered
    • 11.13.3 Orchard Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Orchard Therapeutics Main Business Overview
    • 11.13.5 Orchard Therapeutics Latest Developments
  • 11.14 Human Stem Cells Institute
    • 11.14.1 Human Stem Cells Institute Company Information
    • 11.14.2 Human Stem Cells Institute DNA Medicine Based on DNA Modification Product Offered
    • 11.14.3 Human Stem Cells Institute DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Human Stem Cells Institute Main Business Overview
    • 11.14.5 Human Stem Cells Institute Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on DNA Medicine Based on DNA Modification. Industry analysis & Market Report on DNA Medicine Based on DNA Modification is a syndicated market report, published as Global DNA Medicine Based on DNA Modification Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of DNA Medicine Based on DNA Modification market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,045.12
6,090.24
3,528.24
7,056.48
507,202.80
1,014,405.60
298,399.80
596,799.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report